ArticleAdvances in therapy2024

Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study.

Guoying Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.